Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Aseptic Handling During Inoculation – V 2.0

Posted on By


Biosimilars: SOP for Aseptic Handling During Inoculation – V 2.0


Standard Operating Procedure for Aseptic Handling During Inoculation in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/108/2025
Supersedes SOP/BS/108/2022
Page No. Page 1 of 12
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To outline the aseptic techniques and procedural steps required during inoculation of seed cultures into production bioreactors in biosimilar upstream processes, thereby minimizing the risk of contamination.

2. Scope

This SOP applies to all inoculation activities performed in cleanroom Grade B and C classified areas where seed cultures are transferred to bioreactors within the biosimilars manufacturing facility.

3. Responsibilities

  • Production Operator: Perform inoculation aseptically and maintain documentation.
  • Supervisor: Verify readiness of systems and approve inoculation process.
  • QA: Oversee compliance with aseptic practices and review batch records.

4. Accountability

The Head of Production is accountable for ensuring that inoculation procedures are carried out aseptically and in compliance with GMP standards.

5. Procedure

5.1 Preparation and Environment Setup

  1. Ensure the inoculation area is cleaned and disinfected using 70% IPA or validated biocide.
  2. Verify HVAC parameters (temperature, humidity, pressure differentials) meet specifications.
  3. Perform area clearance and fill Annexure-1: Pre-Inoculation Checklist.

5.2 Personnel Preparation

  1. Only trained personnel qualified in aseptic handling may participate.
  2. Perform full Grade B gowning procedure:
    • Sterile coveralls, masks, goggles, gloves, and footwear
  3. Disinfect gloves periodically during handling.

5.3 Equipment and Material Preparation

  1. Sanitize all transfer tubing, connectors, and clamps using 70% IPA.
  2. Ensure seed bioreactor and production bioreactor are within validated temperature and DO ranges.
  3. Verify seed culture viability (≥90%) and VCD before inoculation.

5.4 Aseptic Inoculation Procedure

  1. Connect sterile tubing from seed culture vessel to the inoculation port of the bioreactor using aseptic connectors (e.g., AseptiQuik).
  2. Initiate transfer using peristaltic pump under laminar flow or closed transfer system.
  3. Monitor for any air bubble formation or leakage.
  4. Upon completion, clamp all lines and disconnect using sterile scissors or welders.

5.5 Post-Inoculation Activities

  1. Close all access ports and start bioreactor agitation and sparging per process parameters.
  2. Document inoculation details in Annexure-2: Inoculation Record.
  3. Send representative culture sample to QC for sterility and viability testing.

6. Abbreviations

  • IPA: Isopropyl Alcohol
  • VCD: Viable Cell Density
  • QC: Quality Control
  • GMP: Good Manufacturing Practice

7. Documents

  1. Pre-Inoculation Checklist – Annexure-1
  2. Inoculation Record – Annexure-2

8. References

  • WHO TRS 961 – Annex 6: GMP for Biological Products
  • EU GMP Annex 1 – Manufacture of Sterile Medicinal Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Pre-Inoculation Checklist

Parameter Status Remarks Checked By
Area Sanitized Yes – Ajay Verma
HVAC Parameters Within range 23°C, 50% RH Sunita Reddy

Annexure-2: Inoculation Record

Date Seed VCD Viability (%) Volume Transferred (L) Bioreactor ID Performed By
04/05/2025 1.8 x 10⁶ 94 4.0 BR-1500A Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Added aseptic connector steps and updated gowning standards Regulatory update
See also  Biosimilars: SOP for Hydrophobic Interaction Chromatography - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: API Manufacturing: SOP for Mock Recall Procedure and Execution – V 2.0
Next Post: Analytical Method Development: Development of Sterility Test Protocol – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version